Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide vs Placebo for Renal Recovery After Hemofiltration
NCT00298454Phase 3Terminated
- Sponsor
- Frisius Medisch Centrum
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of furosemide in acute kidney injury (AKI), sponsored by Frisius Medisch Centrum. Primary endpoints: Recovery of renal function (clearance more than 30 ml/min) and Stable or declining serum creatinin in case of persistent clearance less than 30 ml/min. Started Dec 2005; status: terminated.
02
Drugs
furosemide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00298454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298454.